stock price decline

Pomerantz Law Firm investigates Aardvark Therapeutics after Phase 3 trial pause over cardiac safety issues. Stock crashed 56.2% to $5.47.

Pomerantz Law Firm investigates $FSK over potential securities fraud following steep dividend cut and $440M non-accrual investment disclosure.

Class action lawsuit filed against Apollo Global Management ($APO) over undisclosed Epstein discussions by CEO Marc Rowan. Investors can claim lead plaintiff status until May 1, 2026.

Sunrun stock crashed 35% to $13.25 after reporting 30% net subscriber value decline and negative 2026 guidance, prompting securities fraud investigation.

Pomerantz LLP investigates $UPST over Model 22 underwriting system reducing borrower approvals, triggering sharp stock decline following November disclosure.

Law firm investigates Marriott Vacations for securities fraud following November earnings miss with declining sales and EBITDA.

Pomerantz Law Firm investigates First Western Financial ($MYFW) for potential securities fraud following January 2026 earnings miss; stock fell 8.81% to $24.83.

Pomerantz Law Firm investigates potential securities fraud at Ashford Hospitality Trust following dividend suspension announcement, triggering 8.1% stock decline.

Pomerantz LLP investigates Northern Dynasty Minerals following DOJ's support for EPA veto of Pebble Mine. Stock fell 39.41% on February 18, 2026.

Pomerantz LLP investigates Chagee Holdings for potential securities fraud after $CHA stock plunges 13.14% following disclosure of competitive pressures and rising costs.

Pomerantz Law Firm sues Varonis Systems over alleged securities fraud following October 2025 earnings miss that revealed 63.9% subscription revenue decline and 48.67% stock drop.

BlackRock TCP Capital faces class action lawsuit over 23.4% NAV collapse. Investors have until April 6, 2026, to join litigation.

Pomerantz files class action against Inovio Pharmaceuticals for alleged securities fraud related to false FDA approval statements and concealed manufacturing deficiencies.

Class action lawsuit filed against Ardent Health for accounting irregularities. Stock tumbled 34% after $43M revenue decrease discovery. Lead plaintiff deadline: March 9, 2026.

Robbins LLP investigates CoreWeave ($CRWV) for allegedly misleading investors about demand capabilities and supplier risks. Stock fell from $183.58 to $69.50.

Bragar Eagel & Squire investigates $ODDITY for potential securities violations after algorithm changes caused advertising partner disruption and significant stock decline.

Law firm investigates Eos Energy after stock crashes 39% following Q4 earnings miss. Company blamed production issues and quality control delays for weak results.

Rosen Law Firm investigates $PFSI over alleged misleading disclosures after 33% stock plunge triggered by Q4 servicing income decline.

uniQure's $QURE stock crashes 49% after FDA rejects Huntington's gene therapy approval pathway; securities fraud lawsuit filed alleging misleading statements about regulatory expectations.

Hub Group restates 2025 financials after discovering accounting errors in purchased transportation costs and payables; stock drops 18.3%.